½ÃÀ庸°í¼­
»óǰÄÚµå
1587267

ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀå : Á¦Ç°, À¯Åë ä³Î, ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Cold Pain Therapy Market by Product (OTC Products, Prescription Products), Distribution Channel (E-commerce, Hospital Pharmacy, Retail Pharmacy), Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 199 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀåÀº 2023³â¿¡ 20¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 22¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 8.20%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 35¾ï 6,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÅëÁõ ÇÑ·©¿ä¹ýÀº ÅëÁõ°ú ¿°ÁõÀ» ¿ÏÈ­Çϱâ À§ÇÑ ³Ã¿Â ¿ä¹ýÀ» ¸»ÇÕ´Ï´Ù. ¿©±â¿¡´Â ¾óÀ½ÆÑ, Á©, ½ºÇÁ·¹ÀÌ, ³Ãµ¿ ¿ä¹ýÀ» ½ÃÇàÇÏ´Â ÀåÄ¡ µî ´Ù¾çÇÑ Á¦Ç°ÀÌ Æ÷ÇԵ˴ϴÙ. ÅëÁõ ÇÑ·©¿ä¹ýÀÇ Çʿ伺Àº ºñħ½ÀÀû Ư¼º°ú ½ºÆ÷Ã÷ ºÎ»ó, ¸¸¼º ÅëÁõ ¹× ±Ù°ñ°Ý°è ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ °­Á¶µÇ°í ÀÖ½À´Ï´Ù. ½ºÆ÷Ã÷ ÀÇÇÐ, Á¤Çü¿Ü°ú, ÀçÅÃÄ¡·á µî ´Ù¾çÇÑ ºÐ¾ß¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ëó·Î´Â °³ÀÎ ¼ÒºñÀÚ, ÇÁ·Î ½ºÆ÷Ã÷ ¼±¼ö, ¹°¸®Ä¡·á Ŭ¸®´Ð, ÀÇ·á ½Ã¼³ µîÀÌ ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº °í·ÉÈ­, °Ç°­ °ü¸®¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ºñ¾à¹° ¿ä¹ý¿¡ ´ëÇÑ ¼ö¿äÀÔ´Ï´Ù. ¿þ¾î·¯ºí Äݵå Å×¶óÇÇ ±â±â, »ýºÐÇØ¼º ¹× ģȯ°æ ÆÐŰ¡ÀÇ Çõ½Å°ú °°Àº ±â¼ú ¹ßÀüÀº ºñÁî´Ï½º ±âȸ¸¦ âÃâÇÒ ¼ö ÀÖ½À´Ï´Ù. ƯÈ÷ Äڷγª19 ÀÌÈÄ ¼ÒºñÀÚÀÇ ±¸¸Å ½À°üÀÌ º¯È­ÇÔ¿¡ µû¶ó ¿Â¶óÀÎ ¼Ò¸Å Áõ°¡´Â ½ÃÀå È®´ëÀÇ »õ·Î¿î ä³ÎÀÌ µÉ °ÍÀÔ´Ï´Ù. ±×·¯³ª ÇǺΠÀÚ±ØÀ̳ª µ¿»ó°ú °°Àº ºÎÀÛ¿ëÀÇ °¡´É¼º, ´ëü ¿ä¹ýÀÇ °¡¿ë¼º µîÀÇ ¹®Á¦µµ ÀÖ½À´Ï´Ù. ÁÖ¿ä ±â¾÷µéÀÌ Á¦Ç° Â÷º°È­¿Í Àü·«Àû Á¦ÈÞ¿¡ ÁýÁßÇϸ鼭 °æÀïÀº ´õ¿í Ä¡¿­ÇØÁö°í ÀÖ½À´Ï´Ù. Á¦Ç° ¼ö¸íÁÖ±â ¹× °èÀýÀû ¼ö¿ä º¯µ¿¿¡ µû¸¥ ÇѰè¿Í ¿Â¿­¿ä¹ý µî ´ëü¿ä¹ý°úÀÇ °æÀïÀº ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. Çõ½ÅÀûÀÎ Ä¡·á ºÐ¾ß·Î´Â °³ÀÎ ¸ÂÃãÇü Ä¡·á¸¦ À§ÇÑ IoT ±â¹Ý ³Ãµ¿ Ä¡·á ¼Ö·ç¼Ç°ú Ç¥ÀûÈ­µÈ Àú¿Â Ä¡·á ¾ÖÇø®ÄÉÀÌ¼Ç °³¹ßÀÌ ÇǺΠġ·á ¹× ¼ö¼ú ÈÄ È¸º¹À» À§ÇÑ »õ·Î¿î ±æÀ» ¿­ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷µéÀº ¾ÈÀü¿¡ ´ëÇÑ ¿ì·Á¸¦ ÇØ¼ÒÇϱâ À§ÇØ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇÏ°í ¼ÒºñÀÚ¿¡ ´ëÇÑ Á¦Ç° ±³À°¿¡ ÁýÁßÇÔÀ¸·Î½á ¼ºÀåÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÇコÄɾ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí ÀÖ´Â ½ÅÈï ½ÃÀåÀ» °³Ã´Çϰí À¯Åë¸ÁÀ» È®ÀåÇÔÀ¸·Î½á ¹Ì°³Ã´ ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀÇ Æ¯¼ºÀº ¿ªµ¿ÀûÀ̸ç, ÀüÅëÀû Ä¡·á¿Í Çö´ëÀû Ä¡·á ¼±È£µµ°¡ À¶ÇյǾî ÁøÈ­Çϰí Àֱ⠶§¹®¿¡ ¼ÒºñÀÚÀÇ ¿ä±¸¿Í ±â¼ú ¹ßÀü¿¡ Áö¼ÓÀûÀ¸·Î ÀûÀÀÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 20¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 22¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 35¾ï 6,000¸¸ ´Þ·¯
CAGR(%) 8.20%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®¸¦ °ø°³ÇÕ´Ï´Ù.

³ÃÂòÁú ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ» ÅëÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ºÆ÷Ã÷ Ȱµ¿, ¿îµ¿ ¹× üÀ°°ü¿¡¼­ÀÇ ºÎ»ó ¹ß»ý·ü Áõ°¡
    • ³ë·ÉÀα¸ Áõ°¡¿Í ³ÃÅë¿ä¹ý µµÀÔ
    • ¼¼°è ÀÇ·áºñ Áõ°¡¿Í ÀÎÇÁ¶ó ±¸Ãà
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ³Ãµ¿¿ä¹ý¿¡ ´ëÇÑ ³·Àº ÀÎÁöµµ
    • Ä¡·á¿¡ µû¸¥ ºÎÀÛ¿ë ¹× ºÒÆíÇÔ
  • ½ÃÀå ±âȸ
    • ³Ãµ¿¿ä¹ýÀÇ È¿°ú Çâ»ó
    • ÃÖ±ÙÀÇ ³ÃÅë Ä¡·áÀÇ µ¿Çâ°ú Çõ½ÅÀûÀÎ Ãâ½Ã
  • ½ÃÀå °úÁ¦
    • Àç¿ø ºÎÁ· ¹× ´ëü ¿ä¹ýÀÇ ÀÌ¿ë °¡´É¼º

Portre's Five Forces: ³ÃÅëÁõ Ä¡·á ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ³ÃÂòÁú Ä¡·á ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ³Ã°¨Ä¡·á ½ÃÀå¿¡¼­ÀÇ °æÀï»óȲ ÆÄ¾Ç

ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º Äݵå ÅëÁõ Ä¡·á ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ³ÃÂòÁú Ä¡·á ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀå¿¡¼­ ¼º°øÀÇ ±æÀ» ±×¸®´Ù.

³Ãµ¿Ä¡·áÁ¦ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀå : Á¦Ç°º°

  • ½ÃÆÇ¾à
    • º¸³Ã ÆÑ
    • Á©/¿¬°í/Å©¸²
    • ÆÐÄ¡
    • ·Ñ¿Â
    • ½ºÇÁ·¹ÀÌ ¹× Æû
  • 󹿾à
    • Àüµ¿ µð¹ÙÀ̽º
    • ºñÀüµ¿ µð¹ÙÀ̽º

Á¦7Àå ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀå : À¯Åë ä³Îº°

  • E-Commerce
  • º´¿ø ¾à±¹
  • ¼Ò¸Å ¾à±¹

Á¦8Àå ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀå : ¿ëµµº°

  • Á¤Çü¿Ü°ú Áúȯ
  • ¼ö¼úÈÄ ¿ä¹ý
  • ½É¸®Àû ¿Ü»ó ÈÄ ¿ä¹ý
  • ½ºÆ÷Ã÷ ÀÇÇÐ

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • 3M Company
  • Beiersdorf AG
  • Breg, Inc. by Orthofix US LLC
  • Brownmed, Inc.
  • Cardinal Health, Inc.
  • Compass Health Brands
  • DJO, LLC
  • Hisamitsu Pharmaceutical Co., Inc.
  • Iovera by Pacira BioSciences, Inc.
  • Johnson & Johnson Services, Inc.
  • Medline Industries, LP
  • Performance Health Holding, Inc. by Patterson Medical
  • Sanofi S.A.
  • Unexo Life Sciences Pvt. Ltd.
  • Ossur hf
LSH

The Cold Pain Therapy Market was valued at USD 2.05 billion in 2023, expected to reach USD 2.22 billion in 2024, and is projected to grow at a CAGR of 8.20%, to USD 3.56 billion by 2030.

Cold pain therapy refers to the use of cold treatment to alleviate pain and inflammation. It encompasses a range of products including ice packs, gels, sprays, and devices to deliver cryotherapy. The necessity of cold pain therapy is underscored by its non-invasive nature and the increasing prevalence of sports injuries, chronic pain, and musculoskeletal disorders. It finds applications across various sectors such as sports medicine, orthopedics, and home care. The end-use scope involves individual consumers, professional athletes, physiotherapy clinics, and healthcare facilities. Market growth is driven by an aging population, rising healthcare awareness, and the demand for non-pharmacological treatments. Opportunities arise from technological advancements such as wearable cold therapy devices and innovations in biodegradable and eco-friendly packaging. Increased online retailing offers another channel for market expansion, particularly as consumer shopping habits evolve post-pandemic. However, challenges include potential side effects like skin irritation or frostbite and the availability of alternative therapies. The competitive landscape is intensifying with key players focusing on product differentiation and strategic partnerships. Limitations stem from the product lifecycle and seasonal demand fluctuations, while competition from alternative modalities such as thermal therapy could hinder growth. Innovation areas include IoT-enabled cryotherapy solutions for personalized treatment and the development of targeted cold therapy applications, potentially opening new avenues in therapeutic skin care and post-operative recovery. Businesses can thrive by investing in R&D to address safety concerns and emphasizing product education to consumers. Furthermore, tapping into emerging markets with increasing healthcare investments and expanding the distribution network will help capture untapped opportunities. The nature of this market is dynamic, with a blend of traditional and modern treatment preferences shaping its evolution, demanding continual adaptation to consumer needs and technological advancements.

KEY MARKET STATISTICS
Base Year [2023] USD 2.05 billion
Estimated Year [2024] USD 2.22 billion
Forecast Year [2030] USD 3.56 billion
CAGR (%) 8.20%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cold Pain Therapy Market

The Cold Pain Therapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in the incidence of injuries during sports activity, exercise, and gyming
    • Rising geriatric population and adoption of cold pain therapies
    • Growth in health care expenditure and infrastructure development worldwide
  • Market Restraints
    • Limited awareness regarding cold pain therapies
    • Side effects, and discomfort associated with the treatment
  • Market Opportunities
    • Improvements in efficacy of cold pain therapy
    • Recent developments and innovative launches in the cold pain therapy
  • Market Challenges
    • Lack of reimbursement and availability of substitute therapies

Porter's Five Forces: A Strategic Tool for Navigating the Cold Pain Therapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cold Pain Therapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cold Pain Therapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cold Pain Therapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cold Pain Therapy Market

A detailed market share analysis in the Cold Pain Therapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cold Pain Therapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cold Pain Therapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cold Pain Therapy Market

A strategic analysis of the Cold Pain Therapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cold Pain Therapy Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Beiersdorf AG, Breg, Inc. by Orthofix US LLC, Brownmed, Inc., Cardinal Health, Inc., Compass Health Brands, DJO, LLC, Hisamitsu Pharmaceutical Co., Inc., Iovera by Pacira BioSciences, Inc., Johnson & Johnson Services, Inc., Medline Industries, LP, Performance Health Holding, Inc. by Patterson Medical, Sanofi S.A., Unexo Life Sciences Pvt. Ltd., and Ossur hf.

Market Segmentation & Coverage

This research report categorizes the Cold Pain Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across OTC Products and Prescription Products. The OTC Products is further studied across Cold Packs, Gels, Ointments & Creams, Patches, Roll-Ons, and Sprays & Foams. The Prescription Products is further studied across Motorized Devices and Non-Motorized Devices.
  • Based on Distribution Channel, market is studied across E-commerce, Hospital Pharmacy, and Retail Pharmacy.
  • Based on Application, market is studied across Orthopedic Conditions, Post-Operative Therapy, Post-Trauma Therapy, and Sports Medicine.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the incidence of injuries during sports activity, exercise, and gyming
      • 5.1.1.2. Rising geriatric population and adoption of cold pain therapies
      • 5.1.1.3. Growth in health care expenditure and infrastructure development worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness regarding cold pain therapies
      • 5.1.2.2. Side effects, and discomfort associated with the treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvements in efficacy of cold pain therapy
      • 5.1.3.2. Recent developments and innovative launches in the cold pain therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of reimbursement and availability of substitute therapies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cold Pain Therapy Market, by Product

  • 6.1. Introduction
  • 6.2. OTC Products
    • 6.2.1. Cold Packs
    • 6.2.2. Gels, Ointments & Creams
    • 6.2.3. Patches
    • 6.2.4. Roll-Ons
    • 6.2.5. Sprays & Foams
  • 6.3. Prescription Products
    • 6.3.1. Motorized Devices
    • 6.3.2. Non-Motorized Devices

7. Cold Pain Therapy Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. E-commerce
  • 7.3. Hospital Pharmacy
  • 7.4. Retail Pharmacy

8. Cold Pain Therapy Market, by Application

  • 8.1. Introduction
  • 8.2. Orthopedic Conditions
  • 8.3. Post-Operative Therapy
  • 8.4. Post-Trauma Therapy
  • 8.5. Sports Medicine

9. Americas Cold Pain Therapy Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cold Pain Therapy Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cold Pain Therapy Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Beiersdorf AG
  • 3. Breg, Inc. by Orthofix US LLC
  • 4. Brownmed, Inc.
  • 5. Cardinal Health, Inc.
  • 6. Compass Health Brands
  • 7. DJO, LLC
  • 8. Hisamitsu Pharmaceutical Co., Inc.
  • 9. Iovera by Pacira BioSciences, Inc.
  • 10. Johnson & Johnson Services, Inc.
  • 11. Medline Industries, LP
  • 12. Performance Health Holding, Inc. by Patterson Medical
  • 13. Sanofi S.A.
  • 14. Unexo Life Sciences Pvt. Ltd.
  • 15. Ossur hf
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦